922 related articles for article (PubMed ID: 29619862)
1. Characteristics of patients with coexisting IgA nephropathy and membranous nephropathy.
Chen P; Shi SF; Qu Z; Zhao N; Xie XF; Lv JC; Liu LJ; Zhang H
Ren Fail; 2018 Nov; 40(1):213-218. PubMed ID: 29619862
[TBL] [Abstract][Full Text] [Related]
2. A pilot and comparative study between pathological and serological levels of immunoglobulin and complement among three kinds of primary glomerulonephritis.
Dong J; Peng T; Gao J; Jia X; Yan G; Wang Y
BMC Immunol; 2018 Jun; 19(1):18. PubMed ID: 29925312
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathological features of idiopathic membranous nephropathy combined with IgA nephropathy: a retrospective analysis of 9 cases.
Hu R; Xing G; Wu H; Zhang Z
Diagn Pathol; 2016 Sep; 11(1):86. PubMed ID: 27624606
[TBL] [Abstract][Full Text] [Related]
4. Glomerular Immunodeposits of Patients with IgA Nephropathy Are Enriched for IgG Autoantibodies Specific for Galactose-Deficient IgA1.
Rizk DV; Saha MK; Hall S; Novak L; Brown R; Huang ZQ; Fatima H; Julian BA; Novak J
J Am Soc Nephrol; 2019 Oct; 30(10):2017-2026. PubMed ID: 31444275
[TBL] [Abstract][Full Text] [Related]
5. Concurrent IgA Nephropathy and Membranous Nephropathy, Is It an Overlap Syndrome?
He JW; Cui DF; Zhou XJ; Chen P; Li Y; Zhang X; Wang YN; Gan T; Liu LJ; Shi SF; Zhu L; Hou P; Lv JC; Zhang H
Front Immunol; 2022; 13():846323. PubMed ID: 35359934
[TBL] [Abstract][Full Text] [Related]
6. Clinical significance of serum and mesangial galactose-deficient IgA1 in patients with IgA nephropathy.
Wada Y; Matsumoto K; Suzuki T; Saito T; Kanazawa N; Tachibana S; Iseri K; Sugiyama M; Iyoda M; Shibata T
PLoS One; 2018; 13(11):e0206865. PubMed ID: 30388165
[TBL] [Abstract][Full Text] [Related]
7. Galactose-deficient IgA1 and the corresponding IgG autoantibodies predict IgA nephropathy progression.
Maixnerova D; Ling C; Hall S; Reily C; Brown R; Neprasova M; Suchanek M; Honsova E; Zima T; Novak J; Tesar V
PLoS One; 2019; 14(2):e0212254. PubMed ID: 30794576
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic specificity of autoantibodies to M-type phospholipase A2 receptor (PLA2R) in differentiating idiopathic membranous nephropathy (IMN) from secondary forms and other glomerular diseases.
Radice A; Pieruzzi F; Trezzi B; Ghiggeri G; Napodano P; D'Amico M; Stellato T; Brugnano R; Ravera F; Rolla D; Pesce G; Giovenzana ME; Londrino F; Cantaluppi V; Pregnolato F; Volpi A; Rombolà G; Moroni G; Ortisi G; Sinico RA
J Nephrol; 2018 Apr; 31(2):271-278. PubMed ID: 29081027
[TBL] [Abstract][Full Text] [Related]
9. Ultrasensitive Quantitation of Anti-Phospholipase A2 Receptor Antibody as A Diagnostic and Prognostic Indicator of Idiopathic Membranous Nephropathy.
Zhang Q; Huang B; Liu X; Liu B; Zhang Y; Zhang Z; Hua J; Fan Y; Hu L; Meng M; Wu M; Wang L; Hu Z; Sun Z
Sci Rep; 2017 Sep; 7(1):12049. PubMed ID: 28935926
[TBL] [Abstract][Full Text] [Related]
10. Glomerular Galactose-Deficient IgA1(KM55) Positive May Predict Poorer Prognosis in Coexisting Primary Membranous Nephropathy and IgA Nephropathy Patients.
Cheng W; Wang G; Guo W; Sun L; Xu X; Dong H; Ye S; Geng Y; Cheng H
Cells; 2022 Dec; 12(1):. PubMed ID: 36611910
[TBL] [Abstract][Full Text] [Related]
11. Prevalence, diagnostic value and clinical characteristics associated with the presence of circulating levels and renal deposits of antibodies against the M-type phospholipase A2 receptor in idiopathic membranous nephropathy.
Segarra-Medrano A; Jatem-Escalante E; Quiles-Pérez MT; Salcedo MT; Arbós-Via MA; Ostos H; Valtierra N; Carnicer-Cáceres C; Agraz-Pamplona I
Nefrologia; 2014 May; 34(3):353-9. PubMed ID: 24798555
[TBL] [Abstract][Full Text] [Related]
12. Negative anti-phospholipase A2 receptor antibody status at three months predicts remission in primary membranous nephropathy.
Stefan G; Stancu S; Zugravu A; Popa O; Zubidat D; Petre N; Mircescu G
Ren Fail; 2022 Dec; 44(1):258-268. PubMed ID: 35172682
[TBL] [Abstract][Full Text] [Related]
13. Circulating antibodies to α-enolase and phospholipase A
Kimura Y; Miura N; Debiec H; Morita H; Yamada H; Banno S; Ronco P; Imai H
Clin Exp Nephrol; 2017 Feb; 21(1):117-126. PubMed ID: 26830547
[TBL] [Abstract][Full Text] [Related]
14. Enhanced expression of the M-type phospholipase A2 receptor in glomeruli correlates with serum receptor antibodies in primary membranous nephropathy.
Hoxha E; Kneißler U; Stege G; Zahner G; Thiele I; Panzer U; Harendza S; Helmchen UM; Stahl RA
Kidney Int; 2012 Oct; 82(7):797-804. PubMed ID: 22673885
[TBL] [Abstract][Full Text] [Related]
15. Recurrent IgA nephropathy is predicted by altered glycosylated IgA, autoantibodies and soluble CD89 complexes.
Berthelot L; Robert T; Vuiblet V; Tabary T; Braconnier A; Dramé M; Toupance O; Rieu P; Monteiro RC; Touré F
Kidney Int; 2015 Oct; 88(4):815-22. PubMed ID: 26061544
[TBL] [Abstract][Full Text] [Related]
16. TLR7 in B cells promotes renal inflammation and Gd-IgA1 synthesis in IgA nephropathy.
Zheng N; Xie K; Ye H; Dong Y; Wang B; Luo N; Fan J; Tan J; Chen W; Yu X
JCI Insight; 2020 Jul; 5(14):. PubMed ID: 32699192
[TBL] [Abstract][Full Text] [Related]
17. Membranous nephropathy with crescents: a series of 19 cases.
Rodriguez EF; Nasr SH; Larsen CP; Sethi S; Fidler ME; Cornell LD
Am J Kidney Dis; 2014 Jul; 64(1):66-73. PubMed ID: 24709471
[TBL] [Abstract][Full Text] [Related]
18. Noninvasive diagnosis of primary membranous nephropathy using phospholipase A2 receptor antibodies.
Bobart SA; De Vriese AS; Pawar AS; Zand L; Sethi S; Giesen C; Lieske JC; Fervenza FC
Kidney Int; 2019 Feb; 95(2):429-438. PubMed ID: 30665573
[TBL] [Abstract][Full Text] [Related]
19. Autoantibodies against phospholipase A2 receptor in Korean patients with membranous nephropathy.
Oh YJ; Yang SH; Kim DK; Kang SW; Kim YS
PLoS One; 2013; 8(4):e62151. PubMed ID: 23637987
[TBL] [Abstract][Full Text] [Related]
20. Expression of phospholipase A2 receptor and IgG4 in patients with membranous nephropathy.
Liu L; Chang B; Wu X; Guo Y; Pan Y; Yang L
Vasc Health Risk Manag; 2018; 14():103-108. PubMed ID: 29881283
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
